View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - Terminating coverage

ABGSC ceases coverage of MedicaNatumin …due to end of contractual period Last published estimates are shown in this report

MEDNA MEDICA CLINICAL NORD HOLDING AB
01/06/21 January 6, 2021 10 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - COVID-19 headwinds continue

Norway underpins +18.5% y-o-y sales growth in Q3’20 Confirms 2020e SEK 200m sales target… …new mgmt. to announce new strategic plan in Q1’21

MEDNA MEDICA CLINICAL NORD HOLDING AB
10/26/20 October 26, 2020 19 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - Feeling the COVID-19 turbulence

Norway and exports supports +39% y-o-y sales growth Both opportunities and challenges ahead Appears well-positioned for 2020e SEK 200m sales target

MEDNA MEDICA CLINICAL NORD HOLDING AB
08/21/20 August 21, 2020 16 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
PREMIUM
MEDNA Medica Clinical...

MedicaNatumin - ESG profile

MedicaNatumin works actively to ensure sustainable production based solely on renewable energy. Thirty per cent of the total energy comes from solar panels placed on the roofs of production facilities. MedicaNatumin strives to have control of the supply chain through regular audits, while maintaining a clear code of conduct. The firm has been audited according to SMETA’s “four pillars” requirements – an ethical audit program to help companies secure their supply chains. Many of the produ...

MEDNA MEDICA CLINICAL NORD HOLDING AB
08/18/20 August 18, 2020 2 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - On a strong growth path

81% sales growth in Q1’20 Vitalkost contributed to 44% of net sales in Q1’20 0.8-0.7x EV/Sales ‘20e-’21e, 28-10x EV/EBIT ‘20e-’21e

MEDNA MEDICA CLINICAL NORD HOLDING AB
04/23/20 April 23, 2020 16 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - Leaving a challenging 2019 behind

Sales of SEK 75.2m for EBIT margin of 1.5% Well-positioned in new sales channels going into 2020 EV/EBIT of 13.3-11.3x for ’20e-‘22e

MEDNA MEDICA CLINICAL NORD HOLDING AB
03/04/20 March 4, 2020 16 EN
Jesper Birch-Jensen ... (+2)
  • Jesper Birch-Jensen
  • Rickard Anderkrans
MEDNA Medica Clinical...

MedicaNatumin - Acquires Vitalkost AS

Vitalkost AS is a leading Norwegian self-care operator… …with ‘19e revenues of NOK 73m, EBIT NOK 3.5m Price of NOK 26m, EV/Sales 0.36x, EV/EBIT 7.4x

MEDNA MEDICA CLINICAL NORD HOLDING AB
12/16/19 December 16, 2019 5 EN
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch